eMedicine Specialties > Physical Medicine and Rehabilitation > Lower Limb Musculoskeletal Conditions

Hamstring Strain

Jeffrey M Heftler, MD, Interventional Physiatrist, Orthopaedic and Neurosurgical Specialists, Greenwich, CT
Michael F Saulino, MD, PhD, Assistant Professor, Department of Physical Medicine and Rehabilitation, Thomas Jefferson University, MossRehab

Updated: Apr 10, 2009

Introduction

Background

Hamstring injuries are common problems that may result in significant loss of on-field time for many athletes because these injuries tend to heal slowly. Once injury occurs, the patient is at high risk for recurrence without proper rest and rehabilitation.

The hamstring muscles are 3 muscles in the posterior thigh: the semitendinosus, semimembranosus, and biceps femoris. The semitendinosus originates at the ischial tuberosity and inserts at the pes anserine; the semimembranosus originates at the ischial tuberosity and inserts at the posterior medial tibia. The biceps femoris has a long head that originates at the ischial tuberosity and a short head at the posterolateral femur and inserts into the head of the fibula. Both muscles serve as knee flexors and hip extensors. (See image below and Image 1.)

Normal sagittal alignment permits the knee to loc...

Normal sagittal alignment permits the knee to lock in full extension, aided by powerful quadriceps and an intact extensor mechanism. The ground reaction force passes anterior to the "center of rotation" of the knee, while the posterior cruciate ligament, posterior capsule, hamstrings, and gastrocnemius provide a tension band effect.



At heel strike of the gait cycle, the hamstrings actually contribute to knee extension through closed chain kinetics. During the gait cycle, the biceps femoris contracts eccentrically in terminal swing, which is important in the pathology of the injury, as discussed later.1,2,3

Frequency

United States

Hamstring strain is a fairly common injury in physically active individuals.

Mortality/Morbidity

No mortality is associated with hamstring strain; however, morbidity is common, due to pain and reinjury if proper rehabilitation does not occur before the patient returns to preinjury activity levels.

Age

While hamstring injuries can occur in people of any age, incidence increases with age.

Clinical

History

Hamstring strain is a noncontact injury and usually occurs with either acute or insidious onset. Strain injuries frequently are seen in athletes who run, jump, and kick. Avulsion injuries are seen in patients who participate in water-skiing, dancing, weight lifting, and ice-skating. The avulsion injury usually follows a burst of speed, and the patient may report a popping or tearing sensation. The most commonly affected muscle area in the hamstring complex is the short head of the biceps femoris,3 possibly because of its innervation.

  • As with most strain injuries, the injury can occur at the following 4 places:
    • Origin of the muscle
    • Musculotendinous junction
    • Muscle belly
    • Insertion of the muscle
  • Injury is most likely to occur while the musculotendinous junction undergoes maximum strain during eccentric contraction of the hamstrings.
  • The American Medical Association (AMA) has described 3 grades of severity of hamstring injuries.
    • First-degree strain is the result of stretching of the musculotendinous unit and involves tearing of only a few muscle or tendon fibers.
    • Second-degree injury refers to a more severe muscle tear without complete disruption of the musculotendinous unit.
    • Third-degree injury refers to a complete tear of the musculotendinous unit.

Physical

In addition to pain in the posterior thigh, the physical examination may reveal any of the following signs or symptoms:

  • Tenderness over the site of injury
  • Ecchymosis
  • Palpable mass
    • A palpable defect may be felt with severe strains, but swelling and the deep location of the muscle may obscure this finding in the acute stage.
    • Palpate the muscle for a defect with the patient in a prone position and the knee flexed to 90°. This position relaxes the muscle and decreases cramping and pain. Palpate while maintaining slight tension on the muscle.
  • Pain with passive extension of the knee and the hip flexed at 90°, as compared with the noninjured side, which stretches the muscle
  • Pain with resisted knee flexion, which activates the muscle

Causes

Many different causative factors can contribute to hamstring injuries. The most significant causes include the following:

  • Inadequate flexibility of the hamstrings can result in injury. This may be related to the patient having no or a poor stretching routine.
  • Inadequate strength or endurance of the hamstrings with either a side-to-side weakness or an imbalance between the hamstrings and the knee extensors can lead to injury.
  • Muscle fatigue can lead to dyssynergia of muscle contraction.
  • Insufficient warm-up time may be involved.
  • Poor running technique may play a role.
  • Return to activity before complete healing has occurred can lead to recurrence.

Differential Diagnoses

Achilles Tendon Injuries and Tendonitis
Lumbar Degenerative Disk Disease
Lumbosacral Radiculopathy

Other Problems to Be Considered

Trigger points

Workup

Laboratory Studies

  • Hamstring strain is diagnosed primarily by physical examination and history. Lab studies are not of significant assistance in making the diagnosis.

Imaging Studies

  • The diagnosis is typically clinical, but some imaging studies may helpful if the clinical picture is unclear.4
    • Radiographs can rule out an avulsion injury from the ischial tuberosity or other fractures, but they generally are not otherwise of significant help.
    • Ultrasonographic studies may aid the physician when confirming the diagnosis of hamstring strain, but they do not always indicate definitive results. The quality of the study is related to the expertise of the technician and the cooperation of the patient.
    • When a confirmation or grading of a hamstring strain is necessary, magnetic resonance imaging (MRI) is the most sensitive test used when considering the diagnosis of hamstring strain, but it should be used sparingly because of the cost and patient discomfort.3 Some data suggest that MRI is helpful when attempting to predict return in a high-performance athlete in combination with supporting clinical evidence. Studies have shown that more than 6 weeks' delay before return to sport has been reported with the following:
      • Complete transection
      • Involvement of 50% of cross-sectional muscle
      • Ganglionlike fluid collections
      • Hemorrhagelike signal
      • Distal myotendinous tears
      • Deep muscle tears

Other Tests

  • For higher-level athletes, isokinetic muscle-strength testing may quantify muscle weaknesses or imbalances that may lead to a chronic injury or recurrence.

Treatment

Rehabilitation Program

Physical Therapy

The key to successful recovery from a hamstring strain is recognition of the injury and of the severity of the stain. Physical therapy (PT) is the mainstay of treatment. The program depends on the severity of the injury and on the time that has elapsed since the injury. Very few scientific data are available to determine specific rehabilitation and treatment protocols for hamstring injuries. The program below is just a guide and should be tailored to individual patient needs.

  • Acute phase - During the acute phase (1-5 d), most of the treatment is geared toward decreasing the inflammation and maintaining range of motion. As for most strains, PRICE (ie, protection, rest, ice, compression, elevation) is the initial treatment. When the pain has decreased, the therapist may begin painless gentle passive range of motion and active-assistive range of motion. The patient also may benefit from a cane or crutches to aid in ambulation to keep active. Even if a patient with a first-degree injury is feeling better after a few days and wants to return to participating in his or her sport, it is usually recommended that he or she complete a rehabilitation program to avoid chronic injury. Muscle strengthening, balance, and stretching should be emphasized to the patient as a prevention of recurrence.
  • Subacute phase - The subacute phase (5 d to 3 wk) is when the inflammation of the injury appears to be lessening. The goal of treatment in this stage is to begin some active range of motion and start strengthening. Aquatic therapy is helpful in encouraging activity with decreased weight bearing. Pain-free submaximal isometric exercises also are encouraged. A transcutaneous electrical nerve stimulation unit may be used to provide some pain relief at this time. Ice is also helpful to decrease pain and inflammation. The patient also should resume cardiovascular training, which may include swimming with a pull buoy between the legs, and upper extremity exercises.
  • Remodeling phase3 - The remodeling phase (1-6 wk) is when the patient is able to perform isometric exercises at 100% effort without pain. Prone isotonic hamstring exercises are now added to the transcutaneous electrical nerve stimulation unit and ice. Begin unilaterally with ankle weights, using low weight and a high number of repetitions. Slowly increase the weight as tolerated as long as the patient's pain is not increased afterwards. Importantly, do not increase the weight too rapidly because this could lead to a chronic injury.

    Once concentric strengthening is tolerated at a normal level, the patient may begin eccentric strengthening. Because this exercise puts the most strain on the muscle, supervised exercising and slow progression of weight is recommended. In the prone position, the patient performs a unilateral contraction to 90° of knee flexion and then slowly lowers the weight. If the patient experiences pain or stiffness, then decrease the weight to a more tolerable amount. When the affected leg is within 10% of the unaffected leg, then the patient may advance to a more aggressive therapy program. Continued stretching of the hamstring is essential and should occur prior to exercise. Moist heat prior to exercise may provide improved results. A posterior pelvic tilt may help eliminate lumbar compensation.
  • Functional stage - The functional stage is 2 weeks to 6 months. At this point, the patient should have a normal gait pattern and can begin fast walking. When the patient can ambulate for 20-30 minutes at a fast speed without pain or stiffness, short periods of jogging can be added to the fast walking. When the patient can perform a 15- to 30-minute jog, then short periods of sprinting may be added to the jog. Eventually, more sport-specific exercises may be added. Have the patient continue with the hamstring strengthening and stretching throughout this stage.

    During the later stages of therapy, plyometric exercises may be used to increase speed and power during training. These exercises consist of muscle stretching followed by concentric contraction, allowing for a stronger contraction because of muscle facilitation and decreased inhibition. Low-level exercises may be used initially (eg, jumping rope), followed by higher-level exercises as tolerated (eg, side jumping over a low object, jumping onto and off a box). Because the higher level exercises are associated with a higher rate of injury, they should be performed with supervision.
  • Return to play - This can occur anywhere between 3 weeks and 6 months. Isometric strength testing and flexibility testing may be performed prior to returning to play to ensure that no subtle deficits are present that may lead to chronic injury. The clinician must impress upon the patient the importance of stretching and warm-up prior to activities to prevent reinjury. Less than 5 weeks are required before return to play for patients with (1) superficial muscle injury or (2) muscle injury that involves a small cross-section of muscle. In patients whose injury was due to poor biomechanics, care should be taken to correct the underlying cause. The patient should be supervised during stretching and exercise in order to assess poor technique and correct it.

In a study of 59 Australian footballers who had incurred a hamstring strain, Warren et al found evidence that 2 factors — the amount of time it took a player to walk without pain and whether or not the player had suffered a previous hamstring injury — could be used to help predict the length of time needed for the athletes to return to competition and how likely it was that the injury would again recur.5 According to the study, players who needed more than 1 day to walk without pain were more likely to require more than 3 weeks of convalescence before they could again compete.

Surgical Intervention

Need for surgical intervention is extremely rare after a hamstring injury. Surgery is recommended only in the case of complete rupture of the proximal or distal attachment of the myotendinous complex into the bone.6

Medication

The standard choice for medication is nonsteroidal anti-inflammatory drugs (NSAIDs). These medications not only provide analgesia but also can decrease some of the mediators of inflammation. When to administer NSAIDs to achieve the most beneficial effect is debated. One argument is to administer them immediately following injury to avoid side effects that may interfere with muscle remodeling and repair. The other argument is to delay use until 2-4 days after the injury, so they do not interfere with the chemotaxis required for the laying down of new muscle fibers. No consensus has been reached on which approach to timing yields the best outcome.

Nonsteroidal anti-inflammatory drugs

Have analgesic, anti-inflammatory, and antipyretic activities. Their mechanism of action is not known, but they may inhibit cyclo-oxygenase activity and prostaglandin synthesis. Other mechanisms may exist as well, such as inhibition of leukotriene synthesis, lysosomal enzyme release, lipoxygenase activity, neutrophil aggregation, and various cell-membrane functions.


Naproxen (Anaprox, Naprelan, Naprosyn)

Available in both a regular and delayed-release form.

Dosing

Adult

250-500 mg PO bid

Pediatric

5 mg/kg PO bid

Interactions

Coadministration with aspirin increases risk of inducing serious NSAID-related side effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently

Contraindications

Documented hypersensitivity, peptic ulcer disease, recent GI bleeding or perforation, and renal insufficiency

Precautions

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

Acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of drug


Ibuprofen (Motrin, Ibuprin)

DOC for patients with mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis.

Dosing

Adult

400 mg PO q4-6h, 600 mg q6h, or 800 mg q8h while symptoms persist; not to exceed 3.2 g/d

Pediatric

20-70 mg/kg/d PO divided tid/qid; start at lower end of dosing range and titrate; not to exceed 2.4 g/d

Interactions

Coadministration with aspirin increases risk of inducing serious NSAID-related side effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently

Contraindications

Documented hypersensitivity, peptic ulcer disease, recent GI bleeding or perforation, renal insufficiency, or high risk of bleeding

Precautions

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

Caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy


Ketoprofen (Orudis, Actron)

For relief of mild to moderate pain and inflammation. Small doses initially are indicated in small and elderly patients and in those with renal or liver disease. Doses over 75 mg do not increase therapeutic effects. Administer high doses with caution and closely observe patient for response.

Dosing

Adult

25-50 mg PO q6-8h prn; not to exceed 300 mg/d

Pediatric

<3 months: Not established
3 months to 12 years: 0.1-1 mg/kg PO q6-8h
>12 years: Administer as in adults

Interactions

Coadministration with aspirin increases risk of inducing serious NSAID-related side effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently

Contraindications

Documented hypersensitivity

Precautions

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

Caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy

COX-2 inhibitors

Cyclooxygenase 2 (COX-2) inhibitors have a lower incidence of GI bleeding as compared with other NSAIDs, although there is still a risk involved. They should be considered for use in patients with a history of GI bleed or those who have a high risk for a bleed.


Celecoxib (Celebrex)

Primarily inhibits COX-2. COX-2 is considered an inducible isoenzyme, induced by pain and inflammatory stimuli. Inhibition of COX-1 may contribute to NSAID GI toxicity. At therapeutic concentrations, COX-1 isoenzyme is not inhibited, thus incidence of GI toxicity, such as endoscopic peptic ulcers, bleeding ulcers, perforations, and obstructions, may be decreased when compared to nonselective NSAIDs. Seek lowest dose for each patient.
Neutralizes circulating myelin antibodies through anti-idiotypic antibodies; down-regulates pro-inflammatory cytokines, including INF-gamma; blocks Fc receptors on macrophages; suppresses inducer T and B cells and augments suppressor T cells; blocks complement cascade; promotes remyelination; may increase CSF IgG (10%).
Has a sulfonamide chain and is primarily dependent upon cytochrome P450 enzymes (a hepatic enzyme) for metabolism.

Dosing

Adult

200 mg/d PO qd; alternatively, 100 mg PO bid

Pediatric

Not established

Interactions

Coadministration with fluconazole may cause increase in celecoxib plasma concentrations because of inhibition of celecoxib metabolism; coadministration of celecoxib with rifampin may decrease celecoxib plasma concentrations

Contraindications

Documented hypersensitivity

Precautions

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

May cause fluid retention and peripheral edema; caution in compromised cardiac function, hypertension, conditions predisposing to fluid retention; caution in severe heart failure and hyponatremia because may deteriorate circulatory hemodynamics; NSAIDs may mask usual signs of infection; caution in the presence of existing controlled infections; evaluate therapy when symptoms or lab results suggest liver dysfunction

Follow-up

Further Outpatient Care

  • See Physical Therapy section for a discussion of further outpatient care.

Deterrence

  • Prevention of reinjury is dependent upon successful completion of the rehabilitation program and preactivity warm-up and stretching, although there is limited evidence to prove this conclusion.

Prognosis

  • The prognosis usually is good for complete or near complete improvement in 6-18 weeks. Unfortunately, there are patients who develop chronic problems, possibly due to repeated stresses on the tendon that cause tendinosis. In this case, the tendon is not healing properly, and fibrotic changes take place in the tendon.

Patient Education

  • Once the injury has healed and the rehabilitation program has been completed, emphasize the importance of proper warm-up and stretching before participation in vigorous physical activity.
  • For excellent patient education resources, visit eMedicine's Sprains and Strains - First Aid and Emergency Center and Sports Injury Center. Also, see eMedicine's patient education articles Muscle Strain and Sprains and Strains.

Miscellaneous

Medicolegal Pitfalls

  • Failure to diagnose and treat this condition properly could lead to a chronic condition, as well as to a possible worsening of the condition. An athlete may lose game time, as well as practice time.

Multimedia

Normal sagittal alignment permits the knee to loc...

Media file 1: Normal sagittal alignment permits the knee to lock in full extension, aided by powerful quadriceps and an intact extensor mechanism. The ground reaction force passes anterior to the "center of rotation" of the knee, while the posterior cruciate ligament, posterior capsule, hamstrings, and gastrocnemius provide a tension band effect.

References

  1. Schache AG, Wrigley TV, Baker R, et al. Biomechanical response to hamstring muscle strain injury. Gait Posture. Feb 2009;29(2):332-8. [Medline].

  2. Yu B, Queen RM, Abbey AN, et al. Hamstring muscle kinematics and activation during overground sprinting. J Biomech. Nov 14 2008;41(15):3121-6. [Medline].

  3. Silder A, Heiderscheit BC, Thelen DG, et al. MR observations of long-term musculotendon remodeling following a hamstring strain injury. Skeletal Radiol. Dec 2008;37(12):1101-9. [Medline].

  4. Davis KW. Imaging of the hamstrings. Semin Musculoskelet Radiol. Mar 2008;12(1):28-41. [Medline].

  5. Warren P, Gabbe BJ, Schneider-Kolsky M, et al. Clinical predictors of time to return to competition and of recurrence following hamstring strain in elite Australian footballers. Br J Sports Med. Aug 14 2008;[Medline].

  6. Sallay PI, Ballard G, Hamersly S, et al. Subjective and functional outcomes following surgical repair of complete ruptures of the proximal hamstring complex. Orthopedics. Nov 2008;31(11):[Medline].

  7. Agre JC. Hamstring injuries. Proposed aetiological factors, prevention, and treatment. Sports Med. Jan-Feb 1985;2(1):21-33. [Medline].

  8. Baquie P, Reid G. Management of hamstring pain. Aust Fam Physician. Dec 1999;28(12):1269-70. [Medline].

  9. Brukner P. Hamstring injuries. Aust Fam Physician. Jul 1996;25(7):1109-12. [Medline].

  10. Clanton TO, Coupe KJ. Hamstring strains in athletes: diagnosis and treatment. J Am Acad Orthop Surg. Jul-Aug 1998;6(4):237-48. [Medline].

  11. Hartig DE, Henderson JM. Increasing hamstring flexibility decreases lower extremity overuse injuries in military basic trainees. Am J Sports Med. Mar-Apr 1999;27(2):173-6. [Medline].

  12. Hennessey L, Watson AW. Flexibility and posture assessment in relation to hamstring injury. Br J Sports Med. Dec 1993;27(4):243-6. [Medline].

  13. Laskowski E. Concepts in sports medicine. In: Braddom RL, ed. Physical Medicine and Rehabilitation. Philadelphia, Pa: Saunders; 1996:930-1.

  14. Medical Economics Staff. Physician's Desk Reference. 55th ed. Oradell, NJ: Medical Economics Co; 2000:2631-4.

  15. Pomeranz SJ, Heidt RS Jr. MR imaging in the prognostication of hamstring injury. Work in progress. Radiology. Dec 1993;189(3):897-900. [Medline].

  16. Scoggin JF 3rd. Common sports injuries seen by the primary care physician. Part II: Lower extremity. Hawaii Med J. May 1998;57(5):502-5. [Medline].

  17. Speer KP, Lohnes J, Garrett WE Jr. Radiographic imaging of muscle strain injury. Am J Sports Med. Jan-Feb 1993;21(1):89-95; discussion 96. [Medline].

  18. Worrell TW. Factors associated with hamstring injuries. An approach to treatment and preventative measures. Sports Med. May 1994;17(5):338-45. [Medline].

  19. Yamamoto T. Relationship between hamstring strains and leg muscle strength. A follow-up study of collegiate track and field athletes. J Sports Med Phys Fitness. Jun 1993;33(2):194-9. [Medline].

Keywords

hamstring strain, hamstring, pulled muscle, muscle strain, pulled hamstring, pulled muscles, hamstring injury, strained muscle, strained hamstring, hamstring muscle, hamstring pain, hamstring treatment, torn hamstring, hamstring muscles, hamstring tendon, strained muscles, hamstring injury treatment, hamstring pull

Contributor Information and Disclosures

Author

Jeffrey M Heftler, MD, Interventional Physiatrist, Orthopaedic and Neurosurgical Specialists, Greenwich, CT
Jeffrey M Heftler, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation and American Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Michael F Saulino, MD, PhD, Assistant Professor, Department of Physical Medicine and Rehabilitation, Thomas Jefferson University, MossRehab
Michael F Saulino, MD, PhD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, Association of Academic Physiatrists, and Physiatric Association of Spine, Sports and Occupational Rehabilitation
Disclosure: Nothing to disclose.

Medical Editor

Curtis W Slipman, MD, Director, University of Pennsylvania Spine Center; Associate Professor, Department of Physical Medicine and Rehabilitation, University of Pennsylvania Medical Center
Curtis W Slipman, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, Association of Academic Physiatrists, International Association for the Study of Pain, and North American Spine Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Michael T Andary, MD, MS, Residency Program Director, Professor, Department of Physical Medicine and Rehabilitation, Michigan State University College of Osteopathic Medicine
Michael T Andary, MD, MS is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, American Medical Association, and Association of Academic Physiatrists
Disclosure: allergan Honoraria Speaking and teaching

CME Editor

Kelly L Allen, MD, Regional Medical Director, IMX-Medical Management Services
Disclosure: Nothing to disclose.

Chief Editor

Consuelo T Lorenzo, MD, Consulting Staff, Department of Physical Medicine and Rehabilitation, Alegent Health Care, Immanuel Rehabilitation Center
Consuelo T Lorenzo, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation
Disclosure: Nothing to disclose.

Further Reading

Related eMedicine topics:
Adductor Strain
Contusions
Fixed Knee Flexion Deformities, Pediatrics
Groin Injury
Hamstring Injury
Medial Gastrocnemius Strain
Quadriceps Injury

© 1994- by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)